/

Levodopa

CAS 59-92-7

Overview

Levodopa is a dopamine precursor used in the management of Parkinson's disease, often in combination with carbidopa, as well as other conditions associated with parkinsonism

Anant Labs manufacture and furnish high quality Levodopa impurities for global markets. Our Levodopa EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Levodopa

Levodopa

Cat. No.: ANT-LDP-00
CAS: 59-92-7
Mol. Formula: C₉H₁₁NO₄
Mol. Weight: 197.19

Impurities (5)

Chemical structure of Levodopa EP Impurity A

Levodopa EP Impurity A

Cat. No.: ANT-LDP-02
CAS: 27244-64-0
Mol. Formula: C₉H₁₁NO₅
Mol. Weight: 213.19

Chemical structure of Levodopa EP Impurity B

Levodopa EP Impurity B

Cat. No.: ANT-LDP-004
CAS: 60-18-4
Mol. Formula: C₉H₁₁NO₃
Mol. Weight: 181.19

Chemical structure of Levodopa EP Impurity D

Levodopa EP Impurity D

Cat. No.: ANT-LDP-005
CAS: 5796-17-8
Mol. Formula: C₉H₁₁NO₄
Mol. Weight: 197.19

Chemical structure of Levodopa L-Veratryl glycine Impurity

Levodopa L-Veratryl glycine Impurity

Cat. No.: ANT-LDP-003
CAS: 32161-30-1
Mol. Formula: C₁₁H₁₅NO₄
Mol. Weight: 225.24

Chemical structure of Levodopa Related Compound B

Levodopa Related Compound B

Cat. No.: ANT-LDP-01
CAS: 7636-26-2
Mol. Formula: C₁₀H₁₃NO₄
Mol. Weight: 211.21